EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells

Ying Yan, Chenyu Qiu, Wenying Fu, Chongchong Shu, Chenxin Xu, Yinghua Chen, Yiqun Xia, Jundixia Chen, Yunzhi Chen, Ri Cui, Peng Zou, Daoyong Ni

Cancer Research and Treatment · 2026

DOI: 10.4143/crt.2025.508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2026. Verfasst von Ying Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Endoplasmic Reticulum Stress, Pentacyclic Triterpenes, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Zhejiang Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Colon cancer, a predominant contributor to global cancer mortality, is characterized by uncontrolled cell growth in the colon or rectum. Therapeutic progress notwithstanding, including targeted therapies and chemotherapy, the survival rate remains unsatisfactory, especially for patients with advanced colon cancer, underscoring the need for novel strategies to enhance treatment efficacy.Materials and Methods In this study, we employed Western blot analysis to quantify target protein expression levels and immunofluorescence for protein detection and localization. To evaluate drug interactions, we calculated the Combination Index. Intracellular reactive oxygen species (ROS) levels were measured using the DCFH-DA probe. Additionally, we generated target gene-knockdown cell lines via recombinant lentivirus transfection. For in vivo validation, we established a xenograft tumor model in nude mice to assess the therapeutic efficacy of the drug combination.

Results

In the study, we systematically evaluated the combinatorial potential of clinically approved lenvatinib and bioactive celastrol against colorectal cancer pathogenesis. Our results demonstrated that the combination treatment significantly inhibited cancer cell proliferation by enhancing ROS generation. This oxidative stress activated the ATF4-CHOP and JNK signaling pathways, ultimately inducing cell apoptosis as the main cause of death phenomenon.

Conclusion

Our research demonstrates that celastrol potentiates lenvatinib’s anti-tumor effects in colon cancer by inducing ROS-dependent endoplasmic reticulum stress and triggering phosphorylation-dependent JNK pathway activation. These findings reveal a promising combinatorial strategy to enhance therapeutic efficacy in colorectal carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesEndoplasmic Reticulum StressPentacyclic TriterpenesColonic NeoplasmsPhenylurea CompoundsQuinolinesMAP Kinase Signaling SystemAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsMiceXenograft Model Antitumor AssaysCell Line, TumorApoptosisCell ProliferationDrug SynergismMice, Nude

Stichwörter der Autor:innen

CHOPCelastrolColon neoplasmsJNKLenvatinib

Substanzen

Reactive Oxygen SpeciesPentacyclic TriterpenescelastrolPhenylurea CompoundsQuinolineslenvatinib

Autor:innen und Institutionen

  • Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, China.
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Zhejiang, China.
  • Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. zoupeng@wmu.edu.cn.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, China. zoupeng@wmu.edu.cn.
  • Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. daoyongni@163.com.

Förderung

  • Zhejiang Provincial Natural Science Foundation

Zitieren

APA

Yan, Y., Qiu, C., Fu, W., Shu, C., Xu, C., Chen, Y., Xia, Y., Chen, J., Chen, Y., Cui, R., Zou, P., & Ni, D. (2026). Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.508

Vancouver

Yan Y, Qiu C, Fu W, Shu C, Xu C, Chen Y, et al. Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells. Cancer Research and Treatment. 2026. doi:10.4143/crt.2025.508

BibTeX
@article{Yan2026,
  author = {Yan, Ying and Qiu, Chenyu and Fu, Wenying and Shu, Chongchong and Xu, Chenxin and Chen, Yinghua and Xia, Yiqun and Chen, Jundixia and Chen, Yunzhi and Cui, Ri and Zou, Peng and Ni, Daoyong},
  title = {Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells},
  journal = {Cancer Research and Treatment},
  year = {2026},
  doi = {10.4143/crt.2025.508}
}
Kostenlos starten →